| Where do you study? http://www.yadbeyadlehorim.org.il/stmap_64f4fzn.html?parafon.voltaren.olmesartan.viagra lidocaine drugs.com Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized cellular therapies to treat multiple sclerosis (MS) based on its proprietary T-cell technology. Its leading therapy candidate includes Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS.
|